Search Results 1991-2000 of 21539 for platelets

1. A Study to Evaluate Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer - Mayo Clinic

   Platelets (PLT) ≥100,000/mm^3;; Hemoglobin (HgB) ≥ 8.0g/dL;; Total bilirubin ≤ 1.5 x ULN;; Aspartate transaminase (AST)(SGOT) ≤ 3 x ULN;; Alanine ...

2. A Safety Study of SGN-LIV1A in Breast Cancer Patients - Mayo Clinic

   platelet count ≥00,000/μL;; hemoglobin (Hgb) ≥.0 g/dL;; serum bilirubin ≤.5x upper limit of normal (ULN);; serum creatinine ≤.5x ULN;; alanine ...

3. Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   Within 2 weeks prior to initiation of study treatment: Platelets >= 100,000/mcL; Within 2 weeks prior to initiation of study treatment: Total bilirubin ...

4. Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy - Mayo Clinic

   Platelets ≥ 100,000 u/L; Creatinine ≤ 1.5 x upper limit of normal (ULN); Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) ...

5. Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients with Early-Stage Breast Cancer that was Removed by Surgery - Mayo Clinic

   Platelet count ≥ 75,000/mm³; Hemoglobin ≥ 8.0 g/dL (transfusion or other intervention to achieve Hgb ≥ 8.0 g/dL is acceptable); Negative urine or serum ...

6. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery - Mayo Clinic

   Platelet count ≥ 100,000/mm^3; Hemoglobin > 8.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN); SGOT (AST) ≤ 3 x ULN; SGPT (ALT) ≤ 3 x ULN ...

7. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

   Platelet count >= 100,000/mm^3. Total bilirubin =< 1.5 x upper limit of normal (ULN), except for patients with known Gilbert's syndrome. Aspartate ...

8. A Study of Paclitaxel with or without Cixutumumab as Second-Line Therapy for Treating Patients with Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer - Mayo Clinic

   Platelets ≥ 100,000/mcL; Total bilirubin ≤ institutional upper limit of normal (ULN); Aspartate transaminase (AST) (serum glutamic oxaloacetic transaminase ...

9. Combination Therapy Of Pegylated Interferon Alfa-2a And Tenofovir Versus Tenofovir Monotherapy In Chronic Hepatitis B - Mayo Clinic

   Platelet count <90,000 /mm3, hemoglobin <13 g/dL (males) or <12 g/dL (females), absolute neutrophil count <1500 /mm3 (<1000/mm3 for African-Americans) ...

10. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

    Platelet count ≥ 100,000/mm³; Hemoglobin ≥ 10.0 g/dL; Bilirubin ≤ 1.5 times upper limit of normal (ULN); AST and ALT ≤ 2.5 times ULN; Alkaline phosphatase ...